Amgen, which was down slightly when the trades occurred, closed the session up 1.47 percent to $83.29. The stock fell on Jan. 8 after the company had cut its guidance because of a tax credit, but management remained sanguine over the longer term. That could be leading some investors to expect a positive report this afternoon.
Total option volume in the name was almost nine times greater than average in the session.
—By CNBC Contributor David Russell
Additional News: Top Biotech Trades
Additional Views: CBS Bulls Are Poised for Big Gains: Russell
___________________________
Options Trading School:
___________________________
Disclosures:
David Russell is a reporter and writer for OptionMonster. Russell has no positions in AMGN.
___________________________
